Zirlik, A., & Bode, C. (2016). Vitamin K antagonists: Relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. J Thromb Thrombolysis.
استشهاد بنمط شيكاغوZirlik, Andreas, و Christoph Bode. "Vitamin K Antagonists: Relative Strengths and Weaknesses Vs. Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation." J Thromb Thrombolysis 2016.
MLA استشهادZirlik, Andreas, و Christoph Bode. "Vitamin K Antagonists: Relative Strengths and Weaknesses Vs. Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation." J Thromb Thrombolysis 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.